newsfilter
← Latest News
PR Newswire·

TC BioPharm Announces Pricing of $2.0 Registered Direct Offering

TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...